| 000 | 01678 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518054605.0 | ||
| 264 | 0 | _c20200826 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/s13075-019-1968-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTesser, John | |
| 245 | 0 | 0 |
_aEfficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age. _h[electronic resource] |
| 260 |
_bArthritis research & therapy _c08 2019 |
||
| 300 |
_a190 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdiagnosis |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKafka, Shelly | |
| 700 | 1 | _aDeHoratius, Raphael J | |
| 700 | 1 | _aXu, Stephen | |
| 700 | 1 | _aHsia, Elizabeth C | |
| 700 | 1 | _aTurkiewicz, Anthony | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 21 _gno. 1 _gp. 190 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13075-019-1968-x _zAvailable from publisher's website |
| 999 |
_c30022287 _d30022287 |
||